Anti-seizure drug levetiracetam reduces amyloid buildup in the brain

An anti-seizure drug, levetiracetam, shows promise in preventing the buildup of harmful amyloid-beta proteins in the brain, potentially offering a new avenue for Alzheimer's disease prevention. The study, involving animal models and human neurons, found the drug reduces amyloid buildup and protects synapses. This mechanism targets an early stage of Alzheimer's, before significant brain damage occurs. While promising, the drug would need to be administered very early, possibly before symptoms appear, and researchers are developing longer-lasting versions for future preventative treatments.